Stay updated on Anti-CD38 Antibody Trial in CD38+ Malignancies

Sign up to get notified when there's something new on the Anti-CD38 Antibody Trial in CD38+ Malignancies page.
Latest website image capture
Clouds background image

Latest updates to the Anti-CD38 Antibody Trial in CD38+ Malignancies page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the funding lapse notice as well as Revision: v3.4.1 from the page.
    Difference
    0.2%
    Check dated 2026-02-11T06:16:13.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Site-wide notice about government funding and NIH Clinical Center status has been added, with links to cc.nih.gov and opm.gov. The page revision tag has been updated from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-04T04:42:31.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Show glossary toggle added; QC-related label updated to 'Last Update Submitted that Met QC Criteria', capitalization adjusted for 'No FEAR Act Data', and the revision tag changed to 'Revision: v3.4.0' (replacing v3.3.4).
    Difference
    0.1%
    Check dated 2026-01-28T03:04:36.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now displayed, replacing the previous Revision: v3.3.3; this change is limited to metadata and does not alter page content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:56:05.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The Locations section was updated with new trial sites across the United States and internationally, and several existing locations were removed.
    Difference
    2%
    Check dated 2025-12-23T09:14:39.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    PubMed publications note reworded to indicate automatic filling from PubMed, and the page revision updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T18:50:50.000Z thumbnail image

Stay in the know with updates to Anti-CD38 Antibody Trial in CD38+ Malignancies

Enter your email address, and we'll notify you when there's something new on the Anti-CD38 Antibody Trial in CD38+ Malignancies page.